Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.
Press releases published on August 14, 2025
Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal
GlobeNewswire
·
August 14, 2025
- ISS and Glass Lewis, leading independent proxy advisory firms, support reverse stock split proposal - - Webcast to begin at 4:30 p.m. ET / 1:30 p.m. PT - SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a …
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
GlobeNewswire
·
August 14, 2025
POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for …
Celcuity Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 14, 2025
Reported statistically significant and clinically meaningful improvement in both primary endpoints from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial Hazard ratios and improvements in median progression-free survival (“PFS”) are unprecedented …
Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 14, 2025
DARE to PLAY™ Sildenafil Cream on Track for Q4 2025 Launch via 503B Compounding Pathway; Positioned for Product Revenue Beginning in Q4 2025 Positive Interim DSMB Outcome for Ovaprene® Phase 3 Study Supports Continued Enrollment Multiple Grant-Funded …
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
Patient dosing ongoing in CALiPSO-1 trial; on track to report clinical data for CNTY-101 in patients with B-cell-mediated autoimmune diseases by year-end 2025 CNTY-308, a CAR-iT cell therapy functionally comparable to primary T cells, now in IND-enabling …
Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress
GlobeNewswire
·
August 14, 2025
SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new strategy of focusing on our base of routine users of optical …
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities
GlobeNewswire
·
August 14, 2025
Newly-appointed President and CEO, Eric Risser, outlines strategic priorities for 2025 and 2026 Received $70 million upfront cash payment from Sagard Healthcare Partners under a royalty purchase agreement for ZYNYZ® Cash, cash equivalents and marketable …
Ligand Announces Closing of Convertible Senior Notes Offering
GlobeNewswire
·
August 14, 2025
JUPITER, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today that it completed its previously announced offering (the “offering”) of 0.75% convertible senior notes due 2030 (the “notes”). …
Heald Launches First Money-Back Guarantee in Digital Diabetes Reversal
GlobeNewswire
·
August 14, 2025
ALPHARETTA, Ga., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Heald, a pioneering digital health company specializing in Type 2 diabetes reversal through personalized lifestyle interventions, today announced a first of its kind money-back guarantee. Patients who …
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
GlobeNewswire
·
August 14, 2025
WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), today issued the following statement from Ryan Saadi, M.D., M.P.H., Founder and CEO. “Tevogen is an asset-rich enterprise, and we plan on …
Which Gene Therapy Technology Wins? New Data from Spherix Global Insights Reveals Emerging Hematologist Preferences in Beta Thalassemia Care
GlobeNewswire
·
August 14, 2025
EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within the hematology community: whether the future belongs to …
Results of PBGH Transparency Initiative Provide Employers with New Insights on Commercial Health Care Pricing, Quality & Value: Register for Virtual Event 9/24 to Learn More
GlobeNewswire
·
August 14, 2025
Oakland, California, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Leveraging newly available transparency data to identify the real cost and value of commercial health care for self-insured employers, Purchaser Business Group on Health (PBGH), a nonprofit coalition …
Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight
GlobeNewswire
·
August 14, 2025
New York, USA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight The PH-ILD market is driven by increased disease …
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
GlobeNewswire
·
August 14, 2025
New York, USA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The vitiligo treatment landscape is evolving with a shift towards targeted …
Press release: Transparency Notification from Shareholders
GlobeNewswire
·
August 14, 2025
Transparency Notification from Shareholders Ghent, Belgium – 14 August 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure …
Sutter Health Receives $30 Million Kvamme Foundation Gift to Transform Cancer Care in Santa Cruz
GlobeNewswire
·
August 14, 2025
Santa Cruz, Aug. 14, 2025 (GLOBE NEWSWIRE) -- In a transformative act of generosity, the Jean and E. Floyd Kvamme Foundation has committed $30 million to Sutter Health to establish a new, state-of-the-art cancer center in Santa Cruz. This historic gift, …
HydroGraph Partners with Hawkeye Bio to Power Novel Graphene Biosensor Solution for LEAP™ Lung Cancer Test from Ease Healthcare
GlobeNewswire
·
August 14, 2025
VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- HydroGraph Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph”), a leading producer of ultra-pure graphene, today announced its role in a new lung cancer screening product underpinning a collaboration …
U.S. Oral Surgery Management Moves into 31st State
GlobeNewswire
·
August 14, 2025
IRVING, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) – a management services organization that exclusively serves premier oral and maxillofacial surgeons – has secured partnerships with four new practices, including its …
Industry 4.0 Market to Hit $1.6 Trillion Globally by 2030
GlobeNewswire
·
August 14, 2025
Boston, Aug. 14, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Industry 4.0 Technologies: Global Market Through 2030” is projected to increase from $655.2 billion in 2025 to reach $1.6 trillion by 2030, at a compound annual …
NIH Contract Expands DLH’s Position as a Digital Transformation and Cybersecurity Leader
GlobeNewswire
·
August 14, 2025
ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cyber security, science research and development, and systems engineering and integration, today …